American Radium Society

Post Graduate Course

MRI-Based Applications For Radiation Oncology And Brachytherapy

Elin Sigurdson, MD; Fox Chase Cancer Center
The Role of the Surgeon in Preparation for Partial Breast Irradiation
Elizabeth S. Bloom, MD; MD Anderson Cancer Center
The Management and Outcomes of Partial Breast Irradiation
Anuja Jhingran, MD; MD Anderson Cancer Center
MRI in the Treatment and Management of GYN Malignancies
John Davis, MD; MD Anderson Cancer Center
The Utilization of MRI in the Surgical Management of Prostate Cancer
Alan Pollack, MD, PhD; University of Miami Sylvester Cancer Center
MRI-Based Planning and Treatment for IMRT and Proton Therapy
Steven Frank, MD; MD Anderson Cancer Center
MRI-Based Prostate Brachytherapy: Past, Present, and Future
Prajnan Das, MD, MPH; MD Anderson Cancer Center
Modern IORT Indications: Breast, H&N, GI, GU

SCIENTIFIC SESSION #1: CNS Cancer

Moderators: MARK A. HENDERSON, MD; Indiana University School of Medicine
RAYMOND SAWAYA, MD; MD Anderson Cancer Center

(S001) Gamma Knife Radiosurgery (GKRS) in the
Management of Trigeminal Neuralgia (TN): Median 10 Year Follow-Up of 542 Patients
RUFUS MARK, MD
(S002) Evolution of the Neurosurgical Treatment of Brain
Metastases Treatment during the Last 15 Years: Experience at a Large Referral Cancer Center
RAY SAWAYA, MD
(S003) Combined Chloroquine Therapy and Whole Brain Radiotherapy in Patients with Brain Metastases: Clinical Outcomes and Association with IDO2 Gene Single- Nucleotide Polymorphisms
HARRIET B. ELDREDGE, MD
(S004) Tyrosine Kinase Inhibitors and the Treatment of Brain Metastases in Metastatic Renal Cell Carcinoma
JONATHAN VERMA
(S005) Whole Brain Radiotherapy with Simultaneous Integrated Stereotactic Boost for Brain Metastases
BEN J. SLOTMAN, MD, PhD
(S006) Stereotactic Body Radiation Therapy in Spinal Metastases
KAMRAN A. AHMED, BS
(S007) Comparison of Location of Brain Metastases Among Different Diagnoses and Correlation with Brain Volume and Blood Flow
YOICHI WATANABE, PhD

JANEWAY LECTURE

LARRY EINHORN, MD; Indiana University School of Medicine
Testicular Cancer: A Model for a Curable Neoplasm

SCIENTIFIC SESSION #2: GU/GI Cancer

Moderators: ASHESH JANI, MD; Emory University School of Medicine
MARK K. BUYYOUNOUSKI, MD; Fox Chase Cancer Center

(S008) Chemoradiotherapy for HIV Positive Patients with Anal Carcinoma: The University of Southern California / Los Angeles County Hospital Experience
PAUL M. MANDELIN, DO, MS - TRAVEL GRANT WINNER
(S009) The Role of Definitive Radiation Therapy in the Treatment of Carcinoma of Unknown Primary in the Abdomen and Pelvis
PATRICK KELLY, MD, PhD
(S010) Intensity Modulated Radiation Therapy (IMRT) in the Treatment of Squamous Cell Carcinoma of the Anal Canal: Efficacy of a Low Daily Dose to Clinically Negative Regions
JASON A. CALL, MD
(S011) Comparison of Local Excision and APR for Stage I Rectal Adenocarcinoma Using the SEER Database
MICHELLE OLSHESKI, MD
(S012) Surveillance for Stage I Seminoma: Prognostic Factors for Relapse
KENNETH LODIN, MD
(S013) Timing of Post-Operative Radiation Therapy for Patients at High-Risk of Recurrence after Radical Prostatectomy (RP): Analysis from the Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE) Study
CHARLES C. HSU, MD PhD
(S014) Risk of Gleason Grade Inaccuracies in Prostate Cancer Patients Eligible for Active Surveillance
RONALD H. SHAPIRO, MD - TRAVEL GRANT WINNER
(S015) Aspirin Use Reduces the Risk of Biochemical Recurrence Following Prostate Radiotherapy
MARK K. BUYYOUNOUSKI, MD, MS
(S016) Short Term Urinary Morbidity in Prostate Cancer Patients Treated with Brachytherapy with or without External Beam Radiation Therapy
SANA REHMAN, BS

PANEL: Biomarkers and Biologic Agents

Panel Chair:
ANNE TSAO, MD; MD Anderson Cancer Center
MICHAEL O’REILLY, MD; MD Anderson Cancer Center
JAMES WELSH, MD; MD Anderson Cancer Center

KEYNOTE LECTURE

MELISSA HUDSON, MD; St. Jude Children's Research Hospital
Survivorship in Hodgkin Lymphoma

SELF-ASSESSMENT MODULE (SAM)

Prostate Brachytherapy: BRIAN DAVIS, MD; Mayo Clinic

SCIENTIFIC SESSION #3: Pediatric Cancer/ Lymphoma

Moderators: ARNOLD C. PAULINO, MD; Methodist Hospital Research Institute
KENNETH B. ROBERTS, MD; Yale University School of Medicine

(S017) Results of Continuous Quality Control of Involved Field Radiotherapy for Patients with Early-Stage Hodgkin Lymphoma Based on a Central Prospective Review. Comparison of the Results between Two Study Generations of the German Hodgkin Study Group (GHSG)
ROLF-PETER MUELLER, PROF, MD, PhD
(S018) Decreasing Risk for Second Malignant Neoplasms after Hodgkin Lymphoma: A Single-Institution Experience with 35 Years of Follow-Up
KENNETH B. ROBERTS, MD
(S019) Bexxar Protocol CP98-020: Radio-Immunotherapy Results with I-131 Labeled Antibody in Patients with Follicular Non-Hodgkin’s Lymphoma: Median 5-Year Results in 69 Cases
RUFUS MARK, MD
(S020) Comparison of 3D-CRT, IMRT, and Proton Therapy for Patients with Mediastinal Hodgkin Lymphoma on a Phase II Study
BRADFORD S. HOPPE, MD
(S021) Radiation Treatment Planning Using 18FDG-Pet with CT Scan Co-Registration for Lymphoma and Hematologic Malignancies: A Dosimetric Comparison
STEPHANIE TEREZAKIS, MD
(S022) Survival and Local Ccontrol Outcomes in Adult Patients with Localized Ewing Sarcoma
SAFIA K. AHMED
(S023) Proton Radiotherapy for Retinoblastoma: First Reported Clinical Series
DAVID L. ANDOLINO, MD - TRAVEL GRANT WINNER
(S024) Proton Radiotherapy Significantly Lowers Dose to Left Temporal Lobes in Treated Pediatric Patients with Posterior Fossa Tumors
PRISCILLA K. WALKER

SCIENTIFIC SESSION #4: Miscellaneous

Moderators: BRAD HOPPE, MD; Univeristy of Florida
RUFUS J. MARK, MD; Joe Arrington Cancer Research and Treatment Center

(S025) Significant Reduction of Beta-Amyloid in the CNS Ffollowing Radiation: Implications for Treatment in Alzheimer's Disease
ALVARO A. MARTINEZ, MD
(S026) Introduction of a “No Fly” Patient Safety Policy in an Electronic Quality-Checklist Driven Multi-Center Radiation Medicine Department
L. POTTERS, MD
(S027) Heavy Ion Radiation-Induced Non-Targeted Response on Breast Tissue
TONY J. WANG, MD
(S028) Squamous Cell Carcinoma of the Skin in Solid Organ Transplant Recipients: Patterns of Recurrence after Radiation Therapy
JULIE A. BRADLEY, MD - TRAVEL GRANT WINNER
(S029) A Prospective, Multi-Center Study Assessing the Use of Complementary and Alternative Medicine Practices by Patients Undergoing Definitive Radiation Therapy for Breast
Cancer
MEENA S. MORAN, MD
(S030) Evaluation of Rrotational Errors in Liver Stereotactic Body Radiotherapy Treatment Setup
FOSTER D. LASLEY, MD
(S031) Initial Experience with Using Image-Guided Helical Tomotherapy to Treat Cancers of the Scalp
K. KAINZ, MD; J. FRANK WILSON, MD
(S032) Compliance of Checking Port Films on Radiographic Film Versus an Electronic Medical Record System
GEORGE G. CHEN, MD

PANEL: Recent Advances in Gynecologic Oncology

Panel Chair:
KALED ALEKTIAR, MD; Memorial Sloan Kettering Cancer Center
YUKIO SONODA, MD; Memorial Sloan Kettering Cancer Center
ANUJA JHINGRAN, MD; MD Anderson Cancer Center
CATHERYN YASHAR, MD; UC San Diego Moores Cancer Center

PRESIDENTIAL ADDRESS

Quality in Cancer Care
PETER A.S. JOHNSTONE, MD; Indiana University Medical Center

SCIENTIFIC SESSION #5: Young Oncologist Essay Award Winners

Moderators:
PETER A.S. JOHNSTONE, MD, FACR; Indiana University School of Medicine
DREW A. RIDGE, MD, PhD, FACS; Fox Chase Cancer Center

(S033) A New Paradigm in the Interpretation of Observational Studies Evaluating Postoperative Radiation Therapy
HENRY S. PARK, BS
(S034) Evaluation of RTOG Consensus Guidelines for Delineating Nodal CTV Using a Map of PET Positive Lymph Nodes in Cervical Cancer
HIRAL PATEL FONTANILLA, MD
(S035) A County Level Geographic Analysis of the Radiation Oncology Workforce
SANJAY ANEJA, BS
(S036) Elevation in Exhaled Nitric Oxide Predicts Radiation Pneumonitis in Thoracic Irradiation
MATTHEW R. MCCURDY, MD, PhD

SCIENTIFIC SESSION #6: Quality of Life/ Toxicity

Moderators:
DAVID C. ROHDE, MD; Radiation Oncology Associates, Ltd
ANDRE A. KONSKI, MD, MBA, MA, FACR; Wayne State University Physicians Group

(S037) Patient Reported Cognitive Changes After Cancer Treatment: An Internet-based Survivorship Study
CHRISTINE E. HILL-KAYSER, MD
(S038) Transforming Growth Factor Beta-1 (TGF-ß1), a Serum Biomarker of Radiation Induced Fibrosis in Patients Treated with Intracavitary Brachytherapy Accelerated Partial
Breast Irradiation (IBAPBI), Correlates with Measurments by Tissue Compliance Meter (TCM)
A.GABRIELLA WERNICKE, MD, MSC
(S039) Intraoperative High-Dose-Rate Brachytherapy Using Dose-Painting Technique: Evaluation of Safety and Preliminary Clinical Outcomes
LISA K. MORIKAWA, MD
(S040) Augmenting Electronic Oncology Information Systems with an Aspects-Of-Care Reporting Database in a Multi-Ccenter Paperless Radiation Medicine Department
A. KAPUR, PhD

DEBATE: Treatment for Patients with Stage I NSCLC and Poor Lung Function: SBRT vs. Sublobectomy?

Debate Chair:
RITSUKO KOMAKI, MD; MD Anderson Cancer Center
KENNETH ROSENZWEIG, MD; Mt. Sinai Medical Center
JACK ROTH, MD; MD Anderson Cancer Center

SCIENTIFIC SESSION #7: Lung Cancer

Moderators:
BEN MOVSAS, MD; Henry Ford Health System
ROY H. DECKER, MD; Yale University School of Medicine

(S041) SBRT in the Treatment of Multiple Primary Lung Cancers
KIMBERLY M. CREACH, MD
(S042) Definitive Chemoradiation for Non-Small Cell Lung Cancer: Is 74 Gy Sufficient?
L. CHRISTINE FANG, MD - TRAVEL GRANT WINNER
(S043) Stereotactic Body Radiotherapy (SBRT) for Central Lung Tumors
ROY H. DECKER, MD, PhD
(S044) Factors to Predict Long-Term Five Years Overall Survival (OS) among Patients with Limited Small-Cell Lung Cancer Ttreated with Radiation Treatment (RT) and Chemotherapy
RITSUKO KOMAKI, MD
(S045) Lung Consolidation After Stereotactic Body Radiation Therapy (SBRT) for Early Stage Non-Small Cell Lung Cancer (NSCLC): Implications for Tumor Recurrence and Treatment- Related Toxicity
NEAL E. DUNLAP, MD

PANEL: Reducing Toxicity of Therapy for Head and Neck Cancer

Panel Chair:
ERICH STURGIS, MD; MD Anderson Cancer Center
ANDREW TROTTI, MD; Moffitt Cancer Center
HADI SEIKALY, MD; Alberta Health Services
CHRISTOPHER HOLSINGER, MD; MD Anderson Cancer Center

SELF- ASSESSMENT MODULE (SAM)

Combined Modality Therapy of the Esophagus, Stomach, and Pancreas
CHRISTOPHER CRANE, MD; MD Anderson Cancer Center

SCIENTIFIC SESSION #8: Breast Cancer

Moderator: THOMAS BUCHHOLZ. MD; MD Anderson Cancer Center

(S046) The Effect of Radiation on Cosmesis and Complication Rates in Breast Reconstruction Using Temporary Tissue Expanders and Permanent Implants
CHRISTOPHER J. ANKER, MD
(S047) Prognostic Significance of p53 Binding Protein 1 (53BP1) in Early Stage Breast Cancer
H.J. NEBOORI, BS - TRAVEL GRANT WINNER
(S048) A Matched Pair Analysis Comparing Multi-Lumen Breast Brachytherapy Catheters: Contura Versus SAVI
DANIEL REED, DO
(S049) High Risk of Regional Nodal Failures in Inflammatory Breast Cancer Patients Treated with Trimodality Therapy
KUNAL SAIGAL, MD
(S050) Prospective Randomized Trial of 5-Fluorouracil, Doxorubicin, and Cyclophosphamide (FAC) Versus Paclitaxel and FAC (TFAC) in Patients with Operable Breast Cancer: Impact of Taxane Chemotherapy on Locoregional Control
JEFFREY M. ALBERT, MD - TRAVEL GRANT WINNER
(S051) Molecular Class as a Predictor of Locoregional and Distant Recurrence in the Neoadjuvant Setting for Breast Cancer
JOHN A. VARGO, BA - TRAVEL GRANT WINNER
(S052) Long-Term Outcome of Breast Conservation Therapy for Patients with Ductal Carcinoma In Situ
SIMONA F. SHAITELMAN, MD, EDM

KEYNOTE LECTURE
LIVESTRONG: DOUGLAS ULMAN, President and CEO

SCIENTIFIC SESSION #9: Head and Neck Cancer/ Gynecologic Cancer

Moderators:
JONATHAN JAY BEITLER, MD, MBA, FACR; Emory University School of Medicine
SANDRA HATCH, MD; The University of Texas Medical Branch

(S053) The Impact of Income Level on Clinical Outcomes in Patients with FIGO stage I-II Endometrial Cancer
JARED R. ROBBINS, MD - TRAVEL GRANT WINNER
(S054) Surgicopathological Confirmation of 18F-FDG PET as an Indicator of Cervical Cancer Chemoradiation Therapeutic Response
CHARLES KUNOS, MD, PhD
(S055) Sacral Insufficiency Fractures After Post-Operative Pelvic Radiation Therapy in Gynecologic Malignancy
KARIN K. SHIH
(S056) The Efficacy of Reduced Radiotherapy Dose for Human Papilloma Virus Associated (HPV+) Squamous Cell Carcinoma (SCC) of the Oropharynx Treated with Concurrent Chemoradiation
JOHN F. GRESKOVICH, MD
(S057) Correlation between Metabolic Tumor Volume and Pathologic Tumor Volume in Head and Neck Cancer
JAMES D. MURPHY, MD, MS - TRAVEL GRANT WINNER
(S058) Initial Clinical Outcomes from a Prospective Trial Evaluating Adaptive Radiotherapy for Head and Neck Cancer
DAVID L. SCHWARTZ, MD
(S060) Prognostic Significance of YKL-40 RNA and Protein Levels in Patients with Head and Neck Cancer
BETH M. BEADLE, MD, PhD

PANEL: Credentialing for Emerging New Technology

Panel Chair:
ELIN R. SIGURDSON, MD, PhD; Fox Chase Cancer Center
TIMOTHY WILLIAMS, MD; Lynn Cancer Institute
LEA VITERBO, MD; Fox Chase Cancer Center
GEOFFREY IBBOTT, MD; MD Anderson Cancer Center

American Radium Society